pubmed-article:8485767 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8485767 | lifeskim:mentions | umls-concept:C0079488 | lld:lifeskim |
pubmed-article:8485767 | lifeskim:mentions | umls-concept:C0206668 | lld:lifeskim |
pubmed-article:8485767 | lifeskim:mentions | umls-concept:C2754943 | lld:lifeskim |
pubmed-article:8485767 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8485767 | pubmed:dateCreated | 1993-6-9 | lld:pubmed |
pubmed-article:8485767 | pubmed:abstractText | In conjunction with an investigation extending over several years, focused on the understanding of the importance of Helicobacter pylori in inflammatory gastric disease, the authors examined a group of 1242 patients. In fifteen they detected by microscopic examination the presence of helical bacteria described in the literature as Gastrospirillum hominis. The cultivation test was not positive. In three patients in addition to these bacteria also the presence of Helicobacter pylori was detected. Sera of eight patients with Gastrospirillum hominis were investigated by the ELISA test Helico-G f. Porton Cambridge; antibodies against Helicobacter pylori were found in three patients (incl. two with the concurrent presence of G.h. and H.p.). In sera of the remaining five patients antibodies were not detected. | lld:pubmed |
pubmed-article:8485767 | pubmed:language | slo | lld:pubmed |
pubmed-article:8485767 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8485767 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8485767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8485767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8485767 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8485767 | pubmed:month | Mar | lld:pubmed |
pubmed-article:8485767 | pubmed:issn | 0009-0522 | lld:pubmed |
pubmed-article:8485767 | pubmed:author | pubmed-author:TruplJJ | lld:pubmed |
pubmed-article:8485767 | pubmed:author | pubmed-author:KubonováKK | lld:pubmed |
pubmed-article:8485767 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8485767 | pubmed:volume | 42 | lld:pubmed |
pubmed-article:8485767 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8485767 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8485767 | pubmed:pagination | 22-4 | lld:pubmed |
pubmed-article:8485767 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:meshHeading | pubmed-meshheading:8485767-... | lld:pubmed |
pubmed-article:8485767 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8485767 | pubmed:articleTitle | [IgG antibodies to Gastrospirillum hominis and Helicobacter pylori]. | lld:pubmed |
pubmed-article:8485767 | pubmed:affiliation | Dérerova nemocnica s poliklinikou, Bratislava. | lld:pubmed |
pubmed-article:8485767 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8485767 | pubmed:publicationType | English Abstract | lld:pubmed |